Di-aryl ethers and their derivatives as anti-cancer agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/19 (2006.01) A61K 31/085 (2006.01) A61K 31/09 (2006.01) A61K 31/095 (2006.01) A61K 31/10 (2006.01) A61K 31/11 (2006.01) A61K 31/12 (2006.01) A61K 31/235 (2006.01) A61K 31/65 (2006.01) A61K 41/00 (2006.01) C07C 45/29 (2006.01) C07C 47/575 (2006.01) C07C 65/24 (2006.01) C07C 205/59 (2006.01)

Patent

CA 2285530

The present invention relates, inter alia, to compounds that bind tubulin and exhibit anti-mitotic properties and to methods of using such compounds to inhibit abnormal cell mitosis and, in particular, to inhibit tumor cell growth. In addition, methods are presented of treating mammalian diseases associated with undesired and uncontrolled angiogenesis.

La présente invention porte, entre autre, sur des composés qui fixent la tubuline et présentent des propriétés antimitotiques, et sur des procédés d'utilisation de ces composés destinés à inhiber la mitose des cellules étrangères, et notamment la prolifération cellulaire. De plus, ces procédés sont destinés à traiter les maladies mammaliennes associées à l'angiogenèse indésirable et non maîtrisée.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Di-aryl ethers and their derivatives as anti-cancer agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Di-aryl ethers and their derivatives as anti-cancer agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Di-aryl ethers and their derivatives as anti-cancer agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1839031

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.